REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Revisions for Product Return Reserve Errors and Other Immaterial Corrections (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 12, 2018
Condensed Consolidated Balance Sheet
Inventories	$ 20,905	$ 20,410	$ 40,226	$ 41,098	$ 20,905	$ 40,226	$ 21,568
Accounts receivable, net	19,572	18,731	82,002	65,358	19,572	82,002	40,284
Prepaid expenses and other current assets	24,398	24,703			24,398		32,864
Total current assets	118,447	120,798	308,250	305,139	118,447	308,250	185,182
Goodwill	59,044	59,044	59,044	59,044	59,044	59,044	59,044
Total assets	253,712	280,928	529,882	541,799	253,712	529,882	356,054
Accrued expenses and other current liabilities	56,408	51,079	95,005	114,243	56,408	95,005	75,777
Total current liabilities	92,184	87,656	237,401	258,497	92,184	237,401	129,536
Other non-current liabilities	17,142	16,772	74,610	83,141	17,142	74,610	15,717
Total liabilities	280,519	300,051	470,946	519,221	280,519	470,946	350,824
Accumulated deficit	(1,595,075)	(1,583,903)	(1,496,859)	(1,526,308)	(1,595,075)	(1,496,859)	(1,557,025)
Total liabilities and stockholders' equity	253,712	280,928	529,882	541,799	253,712	529,882	356,054
Condensed Consolidated Statement of Operations and Comprehensive Income
Total revenues	56,376		126,365		96,381	187,988
Cost of goods sold, product	8,273	11,178	9,589	23,105	19,452	32,694
Selling, general and administrative	27,036	25,053	32,240	44,566	52,090	76,806
Operating income (loss)	(8,996)	(25,599)	34,075	(59,581)	(34,594)	(25,504)
Net loss, basic	(11,172)	(26,878)	29,449	(63,509)	(38,050)	(34,058)
Net loss, diluted	(11,172)	(26,878)	29,449	(63,509)	(38,050)	(34,058)
Comprehensive loss	$ (11,172)	$ (26,878)	$ 29,449	$ (63,509)	$ (38,050)	$ (34,058)
Net loss per share - basic (in dollars per share)	$ (0.06)	$ (0.15)	$ 0.16	$ (0.35)	$ (0.20)	$ (0.19)
Net loss per share - diluted (in dollars per share)	$ (0.06)	$ (0.15)	$ 0.15	$ (0.35)	$ (0.20)	$ (0.19)
Condensed Consolidated Statement of Stockholders' (Deficit) Equity
Accumulated deficit	$ (26,807)	$ (19,125)	$ 58,937	$ 22,580	$ (26,807)	$ 58,937	5,230	$ 74,008
Net loss	(11,172)	(26,878)	29,449	(63,509)	(38,050)	(34,058)		(282,024)
Condensed Consolidated Statement of Cash Flows
Net loss	(11,172)	(26,878)	29,449	(63,509)	(38,050)	(34,058)		(282,024)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in excess inventory purchase commitments				0	0	4,854
Changes in operating assets and liabilities:
Accounts receivable		21,553		(13,778)	20,712	(30,421)
Inventory				(8,490)	10,828	(4,362)
Other long-term assets				3,966	(5,876)	10,012
Accrued expense and other current liabilities		(25,115)		7,386	(19,382)	(19,464)
Other long-term liabilities		573			481	(8,622)
Net cash used in operating activities		(17,540)		(21,620)	(13,909)	(52,280)
Accumulated Deficit
Condensed Consolidated Statement of Stockholders' (Deficit) Equity
Accumulated deficit	(1,595,075)	(1,583,903)	(1,496,859)	(1,526,308)	(1,595,075)	(1,496,859)	(1,557,025)	(1,462,799)
Net loss	(11,172)	(26,878)	29,449	(63,509)
Condensed Consolidated Statement of Cash Flows
Net loss	(11,172)	(26,878)	29,449	(63,509)
Product revenue, net
Condensed Consolidated Statement of Operations and Comprehensive Income
Total revenues	$ 42,244	34,706	43,309	41,372	$ 76,950	84,681
As Previously Reported
Condensed Consolidated Balance Sheet
Inventories		20,604	36,272	39,422		36,272
Accounts receivable, net		17,781	81,869	64,582		81,869
Prepaid expenses and other current assets		25,381
Total current assets		120,719	304,163	302,687		304,163
Goodwill		55,053	55,053	55,053		55,053
Total assets		276,858	521,804	535,356		521,804
Accrued expenses and other current liabilities		46,367	91,284	109,660		91,284
Total current liabilities		82,944	233,680	253,914		233,680
Other non-current liabilities		12,643	66,889	77,743		66,889
Total liabilities		291,210	459,504	509,240		459,504
Accumulated deficit		(1,579,130)	(1,493,496)	(1,522,772)		(1,493,496)
Total liabilities and stockholders' equity		276,858	521,804	535,356		521,804
Condensed Consolidated Statement of Operations and Comprehensive Income
Cost of goods sold, product		10,473		22,333		31,923
Selling, general and administrative		25,221	32,807	44,327		77,134
Operating income (loss)		(24,938)	33,902	(58,493)		(24,591)
Net loss, basic		(26,217)	29,276	(62,421)		(33,145)
Net loss, diluted		(26,217)	29,276	(62,421)		(33,145)
Comprehensive loss		$ (26,217)	$ 29,276	$ (62,421)		$ (33,145)
Net loss per share - basic (in dollars per share)		$ (0.14)	$ 0.16	$ (0.35)		$ (0.18)
Net loss per share - diluted (in dollars per share)		$ (0.14)	$ 0.15	$ (0.35)		$ (0.18)
Condensed Consolidated Statement of Stockholders' (Deficit) Equity
Net loss		$ (26,217)	$ 29,276	$ (62,421)		$ (33,145)		(282,840)
Condensed Consolidated Statement of Cash Flows
Net loss		(26,217)	29,276	(62,421)		(33,145)		(282,840)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in excess inventory purchase commitments				(773)		(773)
Changes in operating assets and liabilities:
Accounts receivable		21,399		(13,707)		(30,994)
Inventory				(5,247)		1,159
Other long-term assets				3,297		9,347
Accrued expense and other current liabilities		(25,047)		4,426		(18,625)
Other long-term liabilities		0				(9,030)
Net cash used in operating activities		(17,538)		(21,620)		(52,280)
As Previously Reported | Accumulated Deficit
Condensed Consolidated Statement of Stockholders' (Deficit) Equity
Accumulated deficit		(1,579,130)	(1,493,496)	(1,522,772)		(1,493,496)		(1,460,351)
As Previously Reported | Product revenue, net
Condensed Consolidated Statement of Operations and Comprehensive Income
Total revenues		34,828	43,703	41,448		85,151
Adjustment
Condensed Consolidated Balance Sheet
Inventories		(194)	3,954	1,676		3,954
Accounts receivable, net		950	133	776		133	1,100	700	$ 700
Prepaid expenses and other current assets		(678)
Total current assets		79	4,087	2,452		4,087
Goodwill		3,991	3,991	3,991		3,991				$ 2,600
Total assets		4,070	8,078	6,443		8,078
Accrued expenses and other current liabilities		4,712	3,721	4,583		3,721
Total current liabilities		4,712	3,721	4,583		3,721
Other non-current liabilities		4,129	7,721	5,398		7,721
Total liabilities		8,841	11,442	9,981		11,442
Accumulated deficit		(4,773)	(3,363)	(3,536)		(3,363)
Total liabilities and stockholders' equity		4,070	8,078	6,443		8,078
Condensed Consolidated Statement of Operations and Comprehensive Income
Total revenues							$ 100	1,900	$ 600
Cost of goods sold, product		705		772		771
Selling, general and administrative		(168)	(567)	239		(328)
Operating income (loss)		(661)	173	(1,088)		(913)
Net loss, basic		(661)	173	(1,088)		(913)
Net loss, diluted		(661)	173	(1,088)		(913)
Comprehensive loss		$ (661)	$ 173	$ (1,088)		$ (913)
Net loss per share - basic (in dollars per share)		$ (0.01)	$ 0	$ 0		$ (0.01)
Net loss per share - diluted (in dollars per share)		$ (0.01)	$ 0	$ 0		$ (0.01)
Condensed Consolidated Statement of Stockholders' (Deficit) Equity
Net loss		$ (661)	$ 173	$ (1,088)		$ (913)		816
Condensed Consolidated Statement of Cash Flows
Net loss		(661)	173	(1,088)		(913)		816
Adjustments to reconcile net loss to net cash used in operating activities:
Change in excess inventory purchase commitments				773		5,627
Changes in operating assets and liabilities:
Accounts receivable		154		(71)		573
Inventory				(3,243)		(5,521)
Other long-term assets				669		665
Accrued expense and other current liabilities		(68)		2,960		(839)
Other long-term liabilities		573				408
Net cash used in operating activities		(2)		0		0
Adjustment | Accumulated Deficit
Condensed Consolidated Statement of Stockholders' (Deficit) Equity
Accumulated deficit		(4,773)	(3,363)	(3,536)		(3,363)		$ (2,448)
Adjustment | Product revenue, net
Condensed Consolidated Statement of Operations and Comprehensive Income
Total revenues		$ (122)	$ (394)	$ (76)		$ (470)